Results 51 to 60 of about 71,077 (191)
Conceptual framework for SARS-CoV-2-related lymphopenia
The emerging of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak is associated with high morbidity and mortality rates globally. One of the most prominent characteristics of coronavirus disease-19 (COVID-19) is lymphopenia, which is ...
Azizi, Y. +3 more
core +1 more source
In lymphopenic mice, T cells become activated and undergo lymphopenia-induced proliferation (LIP). However, not all T cells are equally sensitive to lymphopenia.
Laura Knop +10 more
doaj +1 more source
Lymphopenia in treatment-naive relapsing multiple sclerosis
Lymphopenia accompanies some autoimmune diseases. A number of studies, but not others, have suggested that lymphopenia occurs in treatment-naive multiple sclerosis (MS), so the issue remains unresolved. This is important since lymphopenia may identify an
Galea, Ian +3 more
core +1 more source
A Systematic Review of Radiation-Related Lymphopenia in Genito-urinary Malignancies
The impact of radiation-related lymphopenia on clinical outcomes has been reported in various solid malignancies such as high grade gliomas, head and neck cancers, thoracic malignancies and gastro-intestinal malignancies but its impact is not clearly ...
Hagar Elghazawy (11284736) +13 more
core +1 more source
Lymphopenia in sepsis—an acquired immunodeficiency?
AbstractSepsis is a global health priority, yet effective host‐directed targeted therapies have not been identified outside of the setting of coronavirus disease 2019 (COVID‐19). Lymphopenia occurs in up to ~52% of patients with sepsis and is associated with a higher mortality at both 30 and 100 days. In COVID‐19, the presence of lymphopenia correlates
Simon, Finfer +3 more
openaire +2 more sources
Lymphopenia during opportunistic infections.
Lymphopenia during opportunistic infections.
Marius Vögelin (2805241) +9 more
core +1 more source
Risk factors for development of lymphopenia in dimethyl fumarate-treated patients with multiple sclerosis [PDF]
Background: Dimethyl fumarate (DMF, Tecfidera®) is a first-line disease-modifying therapy for relapsing-remitting multiple sclerosis. Lymphopenia is a frequent reason for discontinuation in fumarate-treated patients.
Góra, Monika Katarzyna +11 more
core +1 more source
Background: Associations have been reported between lifestyle-related diseases and evacuation after the Great East Japan Earthquake (GEJE). However, the relationship between lifestyle-related diseases and the effective radiation dose due to external ...
Akira Sakai +13 more
doaj +1 more source
Regulatory T cell ablation causes acute T cell lymphopenia. [PDF]
Regulatory T (Treg) cells enforce T cell homeostasis and maintain peripheral T cell tolerance. Here we report a previously unappreciated phenomenon of acute T cell lymphopenia in secondary lymphoid organs and non-lymphoid tissues triggered by Treg cell ...
Saskia Hemmers (214438) +5 more
core +1 more source
Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: A longitudinal, multinational study [PDF]
OBJECTIVE: The prevalence and associations of leucopenia in SLE remain incompletely understood. We evaluated associations of disease activity and medication use with leucopenia (lymphopenia and neutropenia) in a multinational, prospectively followed SLE ...
Lau, CS +26 more
core +1 more source

